{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Lomitapide  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Lomitapide. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Lomitapide  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "lomitapide",
    "trial_2_text": "Lomitapide  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Lomitapide Supplement: 60 participants will take Lomitapide 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Lomitapide. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Lomitapide  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "87": 0.4015761613845825,
      "78": 0.22515371441841125,
      "64": 0.1718207448720932,
      "17": 0.17104826867580414,
      "228": 0.16803501546382904,
      "67": 0.15225470066070557,
      "189": 0.14889393746852875,
      "20": 0.1450788825750351,
      "77": 0.13999244570732117,
      "9": 0.13943953812122345,
      "188": 0.13504058122634888,
      "37": 0.12667249143123627,
      "68": 0.12490507960319519,
      "177": 0.12424957752227783,
      "123": 0.12291016429662704,
      "243": 0.11992217600345612,
      "46": 0.11707717925310135,
      "49": 0.11658868193626404,
      "101": 0.11441707611083984,
      "173": 0.11386600881814957,
      "79": 0.09914979338645935,
      "200": 0.09636888653039932,
      "21": 0.09565534442663193,
      "85": 0.08089608699083328,
      "104": 0.07891013473272324,
      "239": 0.07890566438436508,
      "126": 0.07745141535997391,
      "29": 0.07379328459501266,
      "86": 0.07358713448047638,
      "114": 0.06814824789762497,
      "5": 0.06760003417730331,
      "350": 0.06727693974971771,
      "82": 0.06599809974431992,
      "139": 0.06508293747901917,
      "136": 0.06283503025770187,
      "179": 0.06282545626163483,
      "151": 0.06253575533628464,
      "193": 0.060827720910310745,
      "122": 0.06065087392926216,
      "102": 0.06059671565890312,
      "72": 0.05977723374962807,
      "18": 0.05615008622407913,
      "355": 0.056015148758888245,
      "131": 0.055557698011398315,
      "422": 0.05516929179430008,
      "28": 0.054972849786281586,
      "211": 0.05317261070013046,
      "116": 0.05310641601681709,
      "27": 0.052896350622177124,
      "14": 0.05283896625041962,
      "191": 0.0515921525657177,
      "76": 0.05151703581213951,
      "382": 0.049990423023700714,
      "261": 0.04981497302651405,
      "132": 0.04973490908741951,
      "147": 0.04963775724172592,
      "371": 0.04891170561313629,
      "121": 0.04877251386642456,
      "339": 0.04776740074157715,
      "204": 0.047690264880657196,
      "341": 0.04698386415839195,
      "282": 0.045189447700977325,
      "33": 0.04411204904317856,
      "35": 0.04408169910311699,
      "180": 0.04405231401324272,
      "99": 0.04361921548843384,
      "297": 0.04335420951247215,
      "199": 0.04287158325314522,
      "38": 0.04256223514676094,
      "138": 0.042327914386987686,
      "61": 0.04210812225937843,
      "166": 0.042016271501779556,
      "96": 0.04197022318840027,
      "2": 0.04176340997219086,
      "363": 0.04171179607510567,
      "249": 0.040976282209157944,
      "97": 0.040878776460886,
      "256": 0.040550895035266876,
      "456": 0.040330663323402405,
      "152": 0.04015585407614708,
      "164": 0.039828598499298096,
      "343": 0.03936871513724327,
      "466": 0.039064764976501465,
      "186": 0.038444336503744125,
      "92": 0.03797198459506035,
      "195": 0.03776019066572189,
      "288": 0.03774721547961235,
      "30": 0.037594374269247055,
      "118": 0.03713729605078697,
      "130": 0.03701581433415413,
      "194": 0.03701494634151459,
      "69": 0.0367099829018116,
      "454": 0.036652084439992905,
      "36": 0.03640119358897209,
      "286": 0.035854771733284,
      "262": 0.03544975817203522,
      "276": 0.03532683849334717,
      "253": 0.03470902144908905,
      "98": 0.03469964861869812,
      "396": 0.03461378812789917
    },
    "trial_2_ae": {
      "87": 0.4015761613845825,
      "78": 0.22515371441841125,
      "64": 0.1718207448720932,
      "17": 0.17104826867580414,
      "228": 0.16803501546382904,
      "67": 0.15225470066070557,
      "189": 0.14889393746852875,
      "20": 0.1450788825750351,
      "77": 0.13999244570732117,
      "9": 0.13943953812122345,
      "188": 0.13504058122634888,
      "37": 0.12667249143123627,
      "68": 0.12490507960319519,
      "177": 0.12424957752227783,
      "123": 0.12291016429662704,
      "243": 0.11992217600345612,
      "46": 0.11707717925310135,
      "49": 0.11658868193626404,
      "101": 0.11441707611083984,
      "173": 0.11386600881814957,
      "79": 0.09914979338645935,
      "200": 0.09636888653039932,
      "21": 0.09565534442663193,
      "85": 0.08089608699083328,
      "104": 0.07891013473272324,
      "239": 0.07890566438436508,
      "126": 0.07745141535997391,
      "29": 0.07379328459501266,
      "86": 0.07358713448047638,
      "114": 0.06814824789762497,
      "5": 0.06760003417730331,
      "350": 0.06727693974971771,
      "82": 0.06599809974431992,
      "139": 0.06508293747901917,
      "136": 0.06283503025770187,
      "179": 0.06282545626163483,
      "151": 0.06253575533628464,
      "193": 0.060827720910310745,
      "122": 0.06065087392926216,
      "102": 0.06059671565890312,
      "72": 0.05977723374962807,
      "18": 0.05615008622407913,
      "355": 0.056015148758888245,
      "131": 0.055557698011398315,
      "422": 0.05516929179430008,
      "28": 0.054972849786281586,
      "211": 0.05317261070013046,
      "116": 0.05310641601681709,
      "27": 0.052896350622177124,
      "14": 0.05283896625041962,
      "191": 0.0515921525657177,
      "76": 0.05151703581213951,
      "382": 0.049990423023700714,
      "261": 0.04981497302651405,
      "132": 0.04973490908741951,
      "147": 0.04963775724172592,
      "371": 0.04891170561313629,
      "121": 0.04877251386642456,
      "339": 0.04776740074157715,
      "204": 0.047690264880657196,
      "341": 0.04698386415839195,
      "282": 0.045189447700977325,
      "33": 0.04411204904317856,
      "35": 0.04408169910311699,
      "180": 0.04405231401324272,
      "99": 0.04361921548843384,
      "297": 0.04335420951247215,
      "199": 0.04287158325314522,
      "38": 0.04256223514676094,
      "138": 0.042327914386987686,
      "61": 0.04210812225937843,
      "166": 0.042016271501779556,
      "96": 0.04197022318840027,
      "2": 0.04176340997219086,
      "363": 0.04171179607510567,
      "249": 0.040976282209157944,
      "97": 0.040878776460886,
      "256": 0.040550895035266876,
      "456": 0.040330663323402405,
      "152": 0.04015585407614708,
      "164": 0.039828598499298096,
      "343": 0.03936871513724327,
      "466": 0.039064764976501465,
      "186": 0.038444336503744125,
      "92": 0.03797198459506035,
      "195": 0.03776019066572189,
      "288": 0.03774721547961235,
      "30": 0.037594374269247055,
      "118": 0.03713729605078697,
      "130": 0.03701581433415413,
      "194": 0.03701494634151459,
      "69": 0.0367099829018116,
      "454": 0.036652084439992905,
      "36": 0.03640119358897209,
      "286": 0.035854771733284,
      "262": 0.03544975817203522,
      "276": 0.03532683849334717,
      "253": 0.03470902144908905,
      "98": 0.03469964861869812,
      "396": 0.03461378812789917
    }
  },
  "safety": {
    "trial_1_safety": 0.2956409156322479,
    "trial_2_safety": 0.2956409156322479
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.47774121165275574
  }
}